News

Gut bacteria could lead to new treatment for inflammatory arthritis

Studying the trillions of bacteria and other microbes that share our body space could lead to a preventative treatment for immune diseases such as rheumatoid arthritis. It's long been suggested that the bacteria which live in our gut, mouth and elsewhere on our bodies may affect our immune system and lead to the development of certain diseases, including rheumatoid arthritis. But exactly how changes to these bacteria, collectively called the "microbiome", cause disease remains to be discovered. The research, which we awarded £2 million to, aims to unlock the link between gut bacteria and the development of immune diseases. This programme award brings together an international team of researchers, led by the University of Oxford, with partners from Birmingham and University College London, as well as collaborators in the US at Harvard University, New York University and Mount Sinai Hospital, New York. It should shed light on the role of the gut microbiome in early arthritis, established rheumatoid arthritis, a

8 Feb 2016
View

This website uses cookies

Like most websites, this site uses cookies. Some are required to make it work, while others are used for statistical or marketing purposes. If you choose not to allow cookies some features may not be available, such as content from other websites. Please read our Cookie Policy for more information.

Essential cookies enable basic functions and are necessary for the website to function properly.
Statistics cookies collect information anonymously. This information helps us to understand how our visitors use our website.
Marketing cookies are used by third parties or publishers to display personalized advertisements. They do this by tracking visitors across websites.